Decreased number of CD14+TLR4+ monocytes and their impaired cytokine responses to lipopolysaccharide in patients with chronic kidney disease

Abstract

This study aimed to examine the number of circulating Toll-like receptor 4 (TLR4) + CD14+ monocytes in patients with different stages of chronic kidney disease (CKD), their responses to lipopolysaccharide (LPS), and to explore the potential association of the number of TLR4+CD14+ monocytes with clinical laboratory measures. The numbers of TLR4+CD14+, LPS-stimulated TNF-α+CD14+ and interleukin (IL)-6+CD14+ monocytes were determined by flow cytometry in 9 patients with stage 3 CKD, 11 with stage 4 CKD, 16 with stage 5 CKD, and 19 healthy controls (HCs). Their laboratory tests were performed by routine methods and the potential association among these measures was analyzed by Pearson’s correlation analysis. The numbers of CD14+, CD14+TLR4+, LPSstimulated TNF-α+CD14+ and IL-6+CD14+ monocytes in patients with CKD were significantly less than those of HCs (all P<0.05), and were negatively associated with patient disease severity. The number of CD14+TLR4+ monocytes was positively correlated with estimated glomerular filtration rate (eGFR, P<0.001) and the levels of hematocrit (P<0.01), but negatively correlated with the levels of blood urine nitrogen, serum creatinine, and C-reactive protein (P<0.001 for all), in the CKD patients. Our data indicate that significant reduction in the number of TLR4+ monocytes and their impaired responses to LPS may be associated with the progression of CKD in Chinese patients.

Keywords

chronic kidney disease / monocytes / Toll-like receptor 4 / interleukin-6 / tumor necrosis factor-α

References

[1] CollinsAJ, YeeJ. Infectious complications in patients with chronic kidney disease. Adv Chronic Kidney Dis, 2006, 13(3): 197-198 PMID: 16815224

[2] NaqviSB, CollinsAJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis, 2006, 13(3): 199-204 PMID: 16815225

[3] ShinzatoT, NakaiS, AkibaT, et al. . Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int, 1999, 55(2): 700-712 PMID: 9987095

[4] MillerSI, ErnstRK, BaderMW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol, 2005, 3(1): 36-46 PMID: 15608698

[5] Palsson-McDermottEM, O’NeillLA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology, 2004, 113(2): 153-162 PMCID: 1782563 PMID: 15379975

[6] AgneseDM, CalvanoJE, HahmSJ, et al. . Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis, 2002, 186(10): 1522-1525 PMID: 12404174

[7] KumpfO, Giamarellos-BourboulisEJ, KochA, et al. . Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts. Crit Care, 2010, 14(3): R103 PMCID: 2911747 PMID: 20525286

[8] AndoM, ShibuyaA, TsuchiyaK, et al. . Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int, 2006, 70(2): 358-362 PMID: 16738534

[9] GollapudiP, YoonJW, GollapudiS, et al. . Leukocyte tolllike receptor expression in end-stage kidney disease. Am J Nephrol, 2010, 31(3): 247-254 PMID: 20090311

[10] National KidneyF. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39(2Suppl1): S1-S266

[11] LiXJ, ZhangGX, SunN, et al. . Protective effects of erythropoietin on endotoxin-related organ injury in rats. J Huazhong Univ Sci Technolog Med Sci, 2013, 33(5): 680-686 PMID: 24142720

[12] KocM, ToprakA, ArikanH, et al. . Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation. Nephrol Dial Transplant, 2011, 26(3): 955-963 PMID: 20729266

[13] GirndtM, SesterM, SesterU, et al. . Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int, 2001, 59(4): 1382-1389 PMID: 11260399

[14] LienE, MeansTK, HeineH, et al. . Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest, 2000, 105(4): 497-504 PMCID: 289161 PMID: 10683379

[15] AkiraS, TakedaK, KaishoT. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol, 2001, 2(8): 675-680 PMID: 11477402

[16] KatoS, ChmielewskiM, HondaH, et al. . Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol, 2008, 3(5): 1526-1533 PMID: 18701615

[17] ImanishiJ. Expression of cytokines in bacterial and viral infections and their biochemical aspects. J Biochem, 2000, 127(4): 525-530 PMID: 10739941

[18] AbrahamG, SundaramV, SundaramV, et al. . C-Reactive protein, a valuable predictive marker in chronic kidney disease. Saudi J Kidney Dis Transpl, 2009, 20(5): 811-815 PMID: 19736479

[19] DanielskiM, IkizlerTA, McMonagleE, et al. . Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis, 2003, 42(2): 286-294 PMID: 12900810

[20] LorenzenJM, DavidS, RichterA, et al. . TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease—a prospective follow-up study. Nephrol Dial Transplant, 2011, 26(4): 1421-1424 PMID: 21239386

[21] JofreR, Rodriguez-BenitezP, Lopez-GomezJM, et al. . Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol, 2006, 17(12Suppl3): S274-S280 PMID: 17130274

[22] Laude-SharpM, CaroffM, SimardL, et al. . Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int, 1990, 38(6): 1089-1094 PMID: 2127434

[23] TamandlD, BahramiM, WessnerB, et al. . Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock, 2003, 20(3): 224-229 PMID: 12923493